Ureka SARL
Records under this name other than the patents Ureka SARL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,889,627 | Pro-drug peptide with improved pharmaceutical properties Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,691,807 | New Hybrid Oligomers, Their Preparation Process and Pharmaceutical Compositions Containing Them Term ended Ended no later than Mar 17, 2026 · Medium confidence | Term ended | Ended no later than Mar 17, 2026 | Medium confidence |
| US 11,267,861 | Peptide-oligourea foldamer compounds and methods of their use Lapsed on the fee record Ended Mar 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2026 | From the USPTO record |
| US 8,138,145 | Hybrid Oligomers, Their Preparation Process and Pharmaceutical Compositions Containing Them Formerly held Lapsed on the fee record Ended Mar 20, 2024 · Medium confidence | Lapsed on the fee record | Ended Mar 20, 2024 | Medium confidence |
| US 10,414,722 | Bioinspired Catalysis Using Oligourea Helical Foldamers Lapsed on the fee record Ended Sep 17, 2023 · High confidence | Lapsed on the fee record | Ended Sep 17, 2023 | High confidence |
| US 10,233,213 | Foldamer Helix Bundle-Based Molecular Encapsulation Lapsed on the fee record Ended Mar 19, 2023 · High confidence | Lapsed on the fee record | Ended Mar 19, 2023 | High confidence |
| US 7,777,030 | Compositions and Methods for the Treatment and Prevention of Disease Lapsed on the fee record Ended Aug 17, 2022 · High confidence | Lapsed on the fee record | Ended Aug 17, 2022 | High confidence |
| US 7,671,029 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances Term ended Term ended Feb 23, 2022 · From the USPTO record | Term ended | Term ended Feb 23, 2022 | From the USPTO record |
| US 6,908,900 | Compositions and Methods for Enhanced Pharmacological Activity Through Oral and Parenteral Administration of Compositions Comprising Polypeptide Drug Substances and Other Poorly Absorbed Active Ingredients Term ended Term ended Feb 19, 2022 · From the USPTO record | Term ended | Term ended Feb 19, 2022 | From the USPTO record |
| US 7,186,828 | Cyclic Urea Compounds and Preparation Thereof Term ended Term ended Jan 19, 2022 · High confidence | Term ended | Term ended Jan 19, 2022 | High confidence |